Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers

Psychopharmacology

Volumn 193, Issue 2, 2007, Pages 235-245

  Comer, Sandra D ^a,b   Sullivan, Maria A ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

Heroin; Memantine; Opioids; Progressive ratio; Self administration; Subjective effects

Indexed keywords

DIAMORPHINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG QUALITY; DRUG SELF ADMINISTRATION; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

ADMINISTRATION, INTRANASAL; ADULT; BEHAVIOR, ADDICTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MEMANTINE; MOTIVATION; NARCOTICS; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 34347392895     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0775-2     Document Type: Article

References (48)

1. Allen RM, Dykstra LA (2001) N-methyl-d-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. J Pharmacol Exp Ther 298(1):288-297
2. Allen RM, Granger AL, Dykstra LA (2001) The competitive N-methyl-d-aspartate receptor antagonist (-)-6-phosphonomethyl-deca- hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther 307(2):785-792
3. Bisaga A, Evans SM (2004) Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology 172:16-24
4. Bulka A, Wiesenfeld-Hallin Z, Xu XJ (2002) Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan. Brain Res 942:95-100
5. Chen SL, Huang EY, Chow LH, Tao PL (2005) Dextromethorphan differentially affects opioid antinociception in rats. Br J Pharmacol 144(3):400-404
6. Collins ED, Ward AS, McDowell DM, Foltin RW, Fischman MW (1998) The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav Pharmacol 9:587-598
7. Collins ED, Vosburg SK, Ward AS, Haney M, Foltin RW (2006) Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans. Pharmacol Biochem Behav 83:47-55
8. Comer SD, Collins ED, MacArthur RB, Fischman MW (1999) Comparison of intranasal and intravenous heroin self-administration by morphine-maintained humans. Psychopharmacology 143:327-338
9. Craft RM, Lee DA (2005) NMDA antagonist modulation of morphine antinociception in female vs. male rats. Pharmacol Biochem Behav 80:639-649
10. Elliott K, Hynansky A, Inturrisi CE (1994) Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59:361-368
11. Evans SM, Foltin RW, Levin FR, Fischman MW (1995) Behavioral and subjective effects of DN-2327 (pazinaclone) and alprazolam in normal volunteers. Behav Pharmacol 6:176-186
12. Fischer BD, Carrigan KA, Dykstra LA (2005) Effects of N-methyl-d-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J Pain 6(7):425-433
13. Foltin RW, Fischman MW (1992) The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther 261:623-632
14. Fraser HF, Van Horn GD, Martin WR, Wolbach AB, Isbell H (1961) Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs, (B) A short-term "direct" addiction test. J Pharmacol Exp Ther 133:371-387
15. Hamdy MM, Noda Y, Miyazaki M, Mamiya T, Nozaki A, Nita A, Sayed M, Assi AA, Gomaa A, Nabeshima T (2004) Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade. Behav Brain Res 152:263-270
16. Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD (1987) Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 13:93-308
17. Hart CL, Haney M, Foltin RW, Fischman MW (2002) Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology 164:376-384
18. Herman BH, Vocci F, Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and dependence: Medication development issues for opiate addiction. Neuropsychopharmacology 13:269-293
19. Huang EY-K, Liu T-C, Tao P-L (2003) Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn-Schmiedeberg's Arch Pharmacol 368:386-392
20. Kelly TH, Foltin RW, Emurian CS, Fischman MW (1993) Performance-based testing for drugs of abuse: Dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J Anal Toxicol 17:264-272
21. Kim H-S, Jang C-G, Park W-K (1996) Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol Biochem Behav 55:11-17
22. Kornhuber J, Quack G (1995) Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 195:137-139
23. Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm 43(Suppl):91-104
24. Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5(2):160-170
25. Mao J, Price DD, Caruso FS, Mayer DJ (1996) Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 67:361-368
26. Marek P, Ben-Eliyahu S, Gold M, Liebeskind JC (1991) Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 547:77-81
27. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the Digit Symbol Substitution Test (DSST). Behav Res Meth Instrum 14:463-466
28. Miller TP, Taylor JL, Tinklenberg JR (1988) A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics. Neuropsychobiology 19:90-96
29. Mobius HJ (2003) Memantine: An update on the current evidence. Int J Geriatr Psychiatry 18:S47-S54
30. Parsons CG, Danysz W, Quack G (2000) Memantine and the amino-alkyl-cylcohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists-in vitro characterization. Amino Acids 19:157-166
31. Popik P, Danysz W (1997) Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-d-aspartate receptor antagonist, memantine. J Pharmacol Exp Ther 280:854-865
32. Popik P, Skolnick P (1996) The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav 53(4):791-797
33. Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY (2003) Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behav Pharmacol 14:237-244
34. Popik P, Wrobel M, Bisaga A (2006) Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology 31(1):160-170
35. Redwine KE, Trujillo KA (2003) Effects of NMDA receptor antagonists on acute m-opioid analgesia in the rat. Pharmacol Biochem Behav 76:361-372
36. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2005) NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Res Bull 64(6):493-503
37. Schuster CR, Greenwald MK, Johanson CE, Heishman S (1995) Measurement of drug craving during naltrexone-precipitated withdrawal in methadone-maintained volunteers. Exp Clin Psychopharmacol 3:424-431
38. Semenova S, Danysz W, Bespalov A (1999) Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naïve mice. Eur J Pharmacol 378:1-8
39. Tiseo PJ, Inturrisi CE (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY274614. J Pharmacol Exp Ther 264:1090-1096
40. Tiseo PJ, Cheng J, Pasternak GW, Inturrisi CE (1994) Modulation of morphine tolerance by the competitive N-methyl-d-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J Pharmacol Exp Ther 268:195-201
41. Trujillo KA (1995) Effects of noncompetitive N-methyl-d-aspartate receptor antagonists on opiate tolerance and dependence. Neuropsychopharmacology 13:301-307
42. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87
43. Trujillo KA, Akil H (1994) Inhibition of opiate tolerance by non-competitive N-methyl-d-aspartate receptor antagonists. Brain Res 633(1-2):178-188
44. Tzschentke TM, Schmidt WJ (1995) N-methyl-d-aspartate receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40
45. Tzschentke TM, Schmidt WJ (2000) Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward. Psychopharmacology 149:225-234
46. Vosburg SK, Hart CL, Haney M, Foltin RW (2005) An evaluation of the reinforcing effects of memantine in cocaine-dependent humans. Drug Alcohol Depend 79:257-260
47. Wesnes K, Warburton DM (1983) Effects of smoking on rapid information processing performance. Neuropsychobiology 9:223-229
48. Xi ZX, Stein EA (2002) Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat. Psychopharmacology 164(2):144-150